Skip to content
  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjdementia
VJNeurology
Logo
  • Home (current)
  • Diseases
    Parkinson's Disease
    Multiple Sclerosis and Related Disorders
    Headache
    Amyotrophic Lateral Sclerosis
    Epilepsy
    Sleep Disorders
    Stroke
    Neuromuscular Disorders
    Movement Disorders
    View all Diseases
  • Topics
    Biology
    Diagnostics
    Trial Updates
    Treatment
    Prevention
    Surgery
    Imaging
    Genetics
    COVID-19
    View all Topics
  • Conferences
    ESOC 2022
    AAN 2022
    CONy 2022
    AD/PD 2022
    World Sleep 2022
    ACTRIMS 2022
    View all Conferences
  • Features
  • Podcasts
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

AAN 2022

Novel agents to control seizures & target epileptogenesis 1:28
Novel agents to control seizures & target epileptogenesis
Claude Steriade • 24 Mar 2022
Proposal for an updated seizure classification framework in clinical trials 2:30
Proposal for an updated seizure classification framework in clinical trials
Claude Steriade • 24 Mar 2022
The diagnosis and treatment of autoimmune-associated seizures 2:32
The diagnosis and treatment of autoimmune-associated seizures
Claude Steriade • 24 Mar 2022
Global initiatives to improve stroke care 2:06
Global initiatives to improve stroke care
Dileep Yavagal • 3 Apr 2022
The diagnosis of parasomnias 2:02
The diagnosis of parasomnias
Alberto Ramos • 12 Apr 2022
Early and sustained responses to cenobamate across focal seizure subtypes 7:01
Early and sustained responses to cenobamate across focal seizure subtypes
William E. Rosenfeld • 4 Apr 2022
Improving targeted treatment in patients with PNES 1:26
Improving targeted treatment in patients with PNES
William Curt LaFrance Jr • 4 Apr 2022
Real-world studies of CGRP monoclonal antibodies and gepants for migraine 5:33
Real-world studies of CGRP monoclonal antibodies and gepants for migraine
Chia-Chun Chiang • 3 Apr 2022
Upcoming developments in stroke 2:33
Upcoming developments in stroke
Dileep Yavagal • 3 Apr 2022
Inclusiveness in healthcare: adults with IDDs 1:38
Inclusiveness in healthcare: adults with IDDs
Seth M. Keller • 3 Apr 2022
Main challenges in increasing access to mechanical thrombectomy 1:49
Main challenges in increasing access to mechanical thrombectomy
Dileep Yavagal • 3 Apr 2022
Current understanding of the pathophysiology of RBD 3:28
Current understanding of the pathophysiology of RBD
Alberto Ramos • 12 Apr 2022
African ancestry specific locus reduces the effect of the ApoE ε4 allele in Alzheimer’s disease 5:42
African ancestry specific locus reduces the effect of the ApoE ε4 allele in Alzheimer’s disease
Farid Rajabli • 13 Apr 2022
Cenobamate for focal seizures: longer-term efficacy and adverse events 2:54
Cenobamate for focal seizures: longer-term efficacy and adverse events
William E. Rosenfeld • 4 Apr 2022
World Stroke Thrombectomy Day 2:03
World Stroke Thrombectomy Day
Dileep Yavagal • 3 Apr 2022
Theories of REM sleep 4:15
Theories of REM sleep
Alberto Ramos • 12 Apr 2022
  • 1
  • 2
  • 3
  • 4
  • Next
Journal Pages
  • Diseases
  • Topics
  • Medicines
  • Trials
  • Conferences
  • Features
Newsletter

Receive the latest news and videos from VJNeurology via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJNeurology logo
The content of VJNeurology is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy